OHB's Half-Year Numbers Reveal a Company Growing Faster Than Its Share Price Can Handle

OHB's H1 2026 shows strong operational growth and record backlog, but one-off capital raise costs dragged net profit down, causing a 16% stock drop.

The arithmetic of OHB's first half of 2026 is straightforward on the surface: revenue up, margins up, order book at a record high. Yet the market's verdict on the Bremen-based space contractor has been anything but celebratory, with the stock shedding roughly 16 percent over the past month as investors digest the mechanics of a capital raise that has temporarily scrambled the company's profit picture.

The June equity placement, which brought in gross proceeds of around €484 million through the issuance of 1,613,023 new shares at €300 apiece, was always going to leave a mark on the income statement. Transaction costs tied to the move — reported as roughly €21.4 million in one source and €22.4 million in another — weighed on the bottom line, dragging net profit down to €4.8 million from €11.5 million a year earlier. That single line item explains much of the disconnect between the operational momentum and the market's muted response.

The Operating Story Is Stronger Than the Headline Numbers Suggest

Strip out those one-off charges and the underlying picture brightens considerably. Adjusted EBITDA climbed 31 percent to €60 million, with the margin expanding from 8.2 percent to 9.6 percent. Adjusted EBIT rose even faster, up 46 percent to €39 million. Group-wide revenue reached €628 million, an 11 percent improvement over the prior-year period.

The two business segments tell a tale of different velocities. Space Systems, which accounts for roughly three-quarters of group output, generated €472 million in revenue, up 8 percent, while its EBIT margin jumped from 4.3 percent to 6.7 percent. The smaller Access to Space division proved the growth engine of the half, with output climbing 31 percent to €105 million.

For the Fuchs family, which retains a 60.3 percent controlling stake, the capital raise has reshaped the ownership register without ceding control. KKR, through its Orchid Lux HoldCo vehicle, now holds 19.7 percent, matching the free float. The expanded shareholder base is expected to pave the way for OHB's inclusion in the TecDAX and SDAX indices in September, a development that could draw fresh institutional interest.

A Record Backlog and a Pipeline of Catalysts

The order book tells a story of its own. At the end of June, OHB's backlog stood at €3.3 billion, up from €3.067 billion a year earlier and the highest in the company's history. That figure positions OHB as one of just three major system integrators for space systems in Europe, a status reinforced in late July when the Italian space agency ASI awarded OHB Italia a contract for the second generation of the PRISMA hyperspectral Earth-observation mission, scheduled to run through the end of 2031.

Looking ahead, the most consequential catalyst is the anticipated IRIS² contract, with signing expected in the second half of 2026. A successful close would demonstrate how the record backlog translates into profitable growth. Strategic partnerships add further texture: a collaboration with Rheinmetall on a protected European communications architecture and the KIRK joint venture with Helsing for space-based reconnaissance. NuWays AG has reaffirmed its "Buy" rating, and the stock remains up more than 100 percent since the start of the year despite the recent pullback.

Where the Bulls and Bears Diverge

Analysts at Deutsche Bank, Jefferies, and Goldman Sachs initiated coverage on Wednesday with price targets ranging from €250 to €360, a spread that reflects differing views on how to weigh operational momentum against the dilution effects of the share issuance. All three targets sit comfortably above the current trading level.

The bear case centers on execution risk in complex space programs. The maiden flight of Rocket Factory Augsburg's RFA rocket has slipped, though a launch in 2026 remains the stated goal. The stock, which closed Friday at €233.50, sits 65.92 percent below its 52-week high of €688.00 from May 2026 and below its 50-day moving average. The relative strength index of 38.7 hints at stabilization, but annualized volatility near 58 percent underscores how jittery the market remains. A 52-week low of €64.00 looks distant given the company's €5.16 billion market capitalization, yet the share price is also trading under its 200-day average of €247.60 — a level that, if reclaimed, could signal the start of a base.

The Second Half Will Settle the Debate

Management has reaffirmed its full-year guidance for an adjusted EBITDA margin in the double digits, and the autumn's detailed business update should reveal whether that stability is translating into operational margins. The near-term direction, however, hinges on milestones rather than forecasts: progress on IRIS², the RFA launch, and the absence of further one-off charges. Until then, the market appears content to let the capital raise's aftertaste linger, even as the underlying business posts numbers that, in any other context, would be cause for celebration.